Company Filing History:
Years Active: 1994-2006
Title: Innovations by David Thompson Berg
Introduction
David Thompson Berg is a notable inventor based in Beech Grove, Indiana, with a remarkable portfolio of 14 patents. His work primarily focuses on advancements in the field of biochemistry, particularly in the development of novel therapeutic proteins.
Latest Patents
One of his latest patents involves the creation of Protein C derivatives. These innovative polypeptides maintain the biological activity of the wild-type human protein C while exhibiting significantly longer half-lives in human blood. This advancement allows for less frequent administration and/or smaller dosages compared to the wild-type human protein C, making it particularly beneficial in treating vascular occlusive disorders, hypercoagulable states, thrombotic disorders, and conditions that predispose individuals to thrombosis. Additionally, he has developed methods for modulating the NF-kB transcription factor, which plays a crucial role in various cellular processes.
Career Highlights
David Thompson Berg is currently associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His contributions to the field have been instrumental in advancing therapeutic options for patients.
Collaborations
Throughout his career, Berg has collaborated with esteemed colleagues, including Brian W Grinnell and Mark Alan Richardson, further enhancing the impact of his work in the scientific community.
Conclusion
David Thompson Berg's contributions to the field of biochemistry through his innovative patents exemplify the importance of research and development in improving medical treatments. His work continues to pave the way for advancements in therapeutic proteins and their applications in medicine.